George L. Fotiades is Director at CANTEL MEDICAL CORP (CMN). They have made 23 open-market trades across 6 companies since 2001, most recently 2026-09-17.
CIK 0001202424
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
14 open-market purchases totalling $2.1M since 2001, against 9 sales. Across 14 scored buys the stock is up 2.8% at ninety days, and 1.4 points behind the S&P over the same stretch.
14 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 14% | 29% | 29% |
| Avg Move | -4.4% | -2.3% | +2.8% |
| Alpha | -0.0% | -4.7% | -1.4% |
| Scored | 14 | 14 | 14 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ATR | SELL | 2023-08-28 | 2023-08-29 | $128.46 | $1.2M | -4.0% | -5.2% | -4.1% |
| ATR | SELL | 2023-08-10 | 2023-08-10 | $122.01 | $1.9M | +1.2% | +4.5% | +3.0% |
| PLD | SELL | 2023-08-01 | 2023-08-02 | $123.99 | $2.7M | +0.9% | +1.8% | -17.6% |
| ATR | SELL | 2021-05-04 | 2021-05-05 | $154.83 | $2.9M | -0.7% | -5.6% | -16.5% |
| PLD | SELL | 2020-06-10 | 2020-06-11 | $96.38 | $258K | -2.3% | -0.0% | +7.9% |
| CMD | BUY | 2020-03-23 | 2020-03-23 | $21.55 | $216K | +44.8% | +21.5% | +93.3% |
| CMD | BUY | 2020-03-16 | 2020-03-16 | $34.22 | $274K | +2.9% | -7.1% | +25.0% |
| CMD | BUY | 2020-03-06 | 2020-03-06 | $52.94 | $265K | -46.4% | -40.5% | -11.1% |
| CMD | BUY | 2020-01-16 | 2020-01-21 | $61.17 | $306K | -2.0% | +5.6% | -56.6% |
| ATR | SELL | 2020-01-15 | 2020-01-17 | $116.66 | $4.4M | -0.1% | -1.2% | -12.7% |
| CMD | SELL | 2017-12-18 | 2018-04-16 | $101.09 | $546K | +1.4% | +11.9% | -15.5% |
| CMD | SELL | 2017-10-13 | 2017-10-17 | $95.23 | $571K | +2.6% | +8.8% | +16.2% |
| PLD | BUY | 2015-05-06 | 2015-05-06 | $39.60 | $317K | -4.4% | -1.1% | -1.1% |
| PLD | BUY | 2012-06-29 | 2012-09-05 | $33.07 | $4K | -4.4% | -1.1% | -1.1% |
| PLD | BUY | 2012-03-30 | 2012-04-03 | $36.22 | $4K | -4.4% | -1.1% | -1.1% |
| ATR | BUY | 2011-08-05 | 2011-08-05 | $47.88 | $239K | -4.3% | +0.1% | +0.1% |
| ACV | SELL | 2010-12-10 | 2010-12-10 | $37.25 | $188K | -9.7% | -0.2% | -0.2% |
| PLD | BUY | 2008-10-28 | 2009-01-13 | $10.99 | $132K | -4.4% | -1.1% | -1.1% |
| CMN | BUY | 2008-07-01 | 2008-07-02 | $9.96 | $50K | -7.1% | -3.4% | -3.4% |
| CMN | BUY | 2008-06-11 | 2008-06-13 | $11.57 | $93K | -7.1% | -3.4% | -3.4% |
| PLD | BUY | 2007-11-09 | 2007-11-13 | $68.00 | $204K | -4.4% | -1.1% | -1.1% |
| ACV | BUY | 2007-02-20 | 2007-12-14 | $25.06 | $827 | -9.7% | -0.2% | -0.2% |
| CAH | BUY | 2001-10-15 | 2006-02-09 | $62.76 | $2K | -10.9% | +0.3% | +0.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.